Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
74.09 USD | +2.43% | -1.49% | -6.91% |
Jun. 05 | Axsome Therapeutics Says It Settled Sunosi Patent Litigation With Unichem Laboratories | MT |
Jun. 05 | RBC Raises Price Target on Axsome Therapeutics to $130 From $127, Keeps Outperform Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.91% | 3.52B | |
+0.99% | 91.72B | |
0.00% | 39.44B | |
-8.52% | 34.47B | |
+65.21% | 26.7B | |
-17.37% | 15.13B | |
-5.99% | 13.27B | |
-10.69% | 11.74B | |
-47.78% | 10.54B | |
+8.09% | 9.41B |
- Stock Market
- Equities
- AXSM Stock
- News Axsome Therapeutics, Inc.
- Piper Sandler Raises Price Target on Axsome Therapeutics to $113 From $90, Maintains Overweight Rating